Potential Benefits and Risks of Large Language Models in Educating Brain Tumor Patients

A review published in Frontiers in Oncology explores the potential benefits and risks of large language models (LLMs) in educating brain tumor patients.

Challenges in Patient Education

Patients with brain tumors often face significant cognitive and emotional burdens, making it difficult to understand the vast amount of medical information required for their care. Existing patient literature typically demands a high-school education or more, severely limiting accessibility for many. Furthermore, consultation times with physicians are often insufficient for patients to fully grasp and retain complex medical details.

Patients with brain tumors often face significant cognitive and emotional burdens, struggling to comprehend complex medical information within limited consultation times.

Opportunities with LLMs

When properly supervised, LLMs can significantly improve patient understanding and involvement in their care. Key opportunities identified include:

Simplifying Information: LLMs possess the capability to explain complex medical procedures, test results, and treatment effects, tailoring the explanation to an individual patient's needs.
Emotional Support: These models can respond politely and with reassurance, potentially offering valuable emotional support to patients who are distressed.
Ongoing Guidance: LLMs can provide continuous patient guidance, extending support and information outside the traditional constraints of clinical settings.

LLMs offer significant opportunities to simplify complex medical information, provide emotional support, and deliver continuous, personalized guidance to brain tumor patients when properly supervised.

Risks and Limitations

Despite their considerable potential, LLMs present several critical challenges that must be addressed:

Inaccuracies: LLMs may generate inaccurate or fabricated information, a phenomenon known as "AI hallucinations," especially concerning treatments or patient outcomes.
Overtrust: Fluent and authoritative-sounding responses from LLMs can lead to patient overtrust, which could potentially hinder collaborative decision-making processes with their clinicians.
Privacy Concerns: The use of LLMs in healthcare raises critical questions regarding the privacy and security of sensitive patient data.
Technical Output: By default, LLM outputs often reside at an undergraduate reading level or higher. This necessitates careful prompt design and thorough clinician training to ensure readability for patients.
Lack of True Insight: LLMs base their responses purely on statistical analysis, fundamentally lacking genuine clinical insight, empathy, or direct accountability. They may also struggle with interpreting sophisticated neuroimaging results accurately.

Despite their potential, LLMs pose significant risks, including generating inaccurate information, fostering patient overtrust, and raising critical privacy concerns.

Ensuring Safe Implementation

To effectively balance the advantages of LLMs with patient safety, diligent oversight, transparent outputs, and mandatory clinician verification are absolutely crucial. A safe framework for integrating LLMs into clinical practice would involve several key components:

Defining Intended Use: Clearly establish the specific roles and boundaries for LLM application.
Structured Prompts: Utilize structured prompts and include mandatory uncertainty disclosure statements in LLM responses.
Ensuring Readability: Guarantee that all LLM outputs are easily understandable for patients.
Clinician Validation: Make clinician validation of all information provided by LLMs mandatory.
Data Privacy: Secure patient portals to protect sensitive data.
Safety Metrics: Establish clear safety metrics, including defined hallucination thresholds and accuracy targets.
Training: Provide comprehensive training for both clinicians and patients on the safe and effective use of AI tools.

Legal responsibility for LLMs in patient education may extend across multiple parties, encompassing manufacturers (for system performance), institutions (for implementation regulation), and individual clinicians (for validating final decisions and information).

Diligent oversight, transparent outputs, and mandatory clinician verification are crucial for safely integrating LLMs into clinical practice for patient education.

Future Research Needs

Further research is essential to validate LLM outputs across various tumor subtypes and to thoroughly study patient interactions. This includes assessing patient understanding, anxiety levels, decision-making processes, and potential overdependence on LLM guidance. Robust real-world validation of patient outcomes remains limited, and continuous refinement of multimodal LLMs and accountability mechanisms are ongoing goals to ensure their safe and effective future use.

Future research must validate LLM outputs, study patient interactions, and establish robust real-world outcomes to ensure safe and effective integration into patient education.